Important Safety Information On Albumin Therapy In Critically-ill Patients – Notice To Hospitals
Albumin Therapy Safety Notice Health Canada has issued a safety notice regarding albumin therapy used in critically-ill patients in hospitals across Canada. The notice provides important safety information for healthcare providers about the use of this blood product in hospital settings. This notice affects hospitals and medical facilities administering albumin to critically-ill patients.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2005-08-18
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/367e4056-862a-408a-a565-7ad789bf4d5e